These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 22814330

  • 1. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
    Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MÁ, Acevedo MJ, González-Roncero FM, Blanco GB, Núñez-Roldán A.
    Transplantation; 2012 Aug 27; 94(4):338-44. PubMed ID: 22814330
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar 27; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Mar 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 4. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 5. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.
    Transplantation; 2013 Jan 15; 95(1):19-47. PubMed ID: 23238534
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec 15; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Transpl Immunol; 2015 Mar 15; 32(2):66-71. PubMed ID: 25661873
    [Abstract] [Full Text] [Related]

  • 10. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 15; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 11. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Oct 15; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 12. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
    Higgins R, Lowe D, Hathaway M, Williams C, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Daga S, Edey M, Zehnder D, Briggs D.
    Transplantation; 2011 Oct 27; 92(8):900-6. PubMed ID: 21968524
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.
    Transplantation; 2009 Jun 15; 87(11):1681-8. PubMed ID: 19502960
    [Abstract] [Full Text] [Related]

  • 14. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 15. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE.
    Transpl Int; 2006 Feb 27; 19(2):128-39. PubMed ID: 16441362
    [Abstract] [Full Text] [Related]

  • 16. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
    Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K.
    Transpl Int; 2012 Sep 27; 25(9):925-34. PubMed ID: 22764746
    [Abstract] [Full Text] [Related]

  • 17. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M, Bosio E, Ancona E, Cozzi E.
    Contrib Nephrol; 2009 Sep 27; 162():87-98. PubMed ID: 19001816
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation.
    Ziemann M, Schönemann C, Bern C, Lachmann N, Nitschke M, Fricke L, Görg S.
    Clin Transplant; 2012 Sep 27; 26(4):644-56. PubMed ID: 22432638
    [Abstract] [Full Text] [Related]

  • 19. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM.
    Transplantation; 2015 Jun 27; 99(6):1151-5. PubMed ID: 25839705
    [Abstract] [Full Text] [Related]

  • 20. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S.
    Transplantation; 2008 Jun 15; 85(11):1557-63. PubMed ID: 18551059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.